Common use of Ownership of Materials and Data Clause in Contracts

Ownership of Materials and Data. It is understood and agreed that: (a) ABX shall solely own all XenoMouse Animals, Genetic Material encoding such XenoMouse Animals, hybridomas and B cells. (b) GNE shall own all Antibodies, Genetic Material encoding Antibodies, and all reagents, samples, data, results, technical information, know-how, preclinical and/or clinical testing data and any other non-patentable information resulting from the parties' use of the Licensed Technology related to the Product Antigen under the MTA or under this Agreement. To the extent that ABX owned any of the foregoing prior to the Effective Date of this Agreement under the terms of the GNE Option Agreement, ownership shall transfer from ABX to GNE as of the Effective Date of this Agreement. (c) With respect to any materials (including, without limitation, all Antibodies, hybridomas or Genetic Material) generated in whole or in part from immunization of XenoMouse Animals with the Product Antigen and/or data made or generated under the MTA, this Section 2.4.3 hereby supersedes and cancels any terms or provisions in the MTA inconsistent with this Section 2.4.3 or any other term of this Agreement. The transfer of physical possession of any materials owned by, and the physical possession and use of such materials and/or data by, GNE or ABX, as the case may be, shall not be (nor be construed as) a sale, lease, offer to sell or lease, or other transfer of title of such materials and/or data to GNE or ABX, as the case may be.

Ownership of Materials and Data. It is understood and agreed that: (a) ABX shall solely own all XenoMouse Animals, Genetic Material encoding such XenoMouse Animals, Antibodies, Genetic Material encoding such Antibodies, hybridomas and B cells. (b) GNE shall own all Antibodies, Genetic Material encoding Antibodies, and all reagents, samples, data, results, technical information, know-how, preclinical and/or clinical testing data and any other non-patentable information resulting from the parties' use of the Licensed Technology related to the Product Antigen under the MTA or under this Agreement. To the extent that ABX owned any of the foregoing prior to the Effective Date of this Agreement under the terms of the GNE Option Agreement, ownership shall transfer from ABX to GNE as of the Effective Date of this Agreement. (c) With respect to any materials (including, without limitation, all Antibodies, hybridomas or Genetic Material) generated in whole or in part from immunization of XenoMouse Animals with the Product Antigen and/or data made or generated under the MTA, this Section 2.4.3 2.1.5 hereby supersedes and cancels any terms or provisions in the MTA inconsistent with this Section 2.4.3 2.1.5 or any other term of this Agreement. The transfer of physical possession of any materials owned by, and the physical possession and use of such materials and/or data by, GNE or ABX, as the case may be, shall not be (nor be construed as) a sale, lease, offer to sell or lease, or other transfer of title of such materials and/or data to GNE or ABX, as the case may be.